Recall
FDAHealthDecember 20, 2024

ENDO USA, Inc. — Adrenalin Chloride Solution (Epinephrine Nasal Solution, USP), 30mg/30mL (1mg/mL), packaged in 30 mL vials, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 42023-103

⚠️ Labeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
December 20, 2024

USA nationwide.

What's affected?

Product
Adrenalin Chloride Solution (Epinephrine Nasal Solution, USP), 30mg/30mL (1mg/mL), packaged in 30 mL vials, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 42023-103-01
Lot code
within

Additional details

All lots within expiry

What should I do?

Recommended action

Class I recall. Voluntary: Firm initiated Quantity affected: 44,397 amber glass vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.